Concepedia

Publication | Open Access

Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM Trial

DOIFull Paper Access

200

Citations

6

References

2020

Year

Jagdeep Singh, Ify Mordi, Keeran Vickneson, Amir Fathi, Peter T. Donnan, Mohapradeep Mohan, Anna Maria Choy, Stephen J. Gandy, Faisel Khan, Ewan R. Pearson,
Diabetes Care

Abstract

We were unable to determine with certainty whether dapagliflozin in patients with T2DM and HF had any effect on LV remodeling. Whether the benefits of dapagliflozin in HF are due to remodeling or other mechanisms remains unknown.

References

YearCitations

Page 1